Overview

INtravitreal and Aqueous Dexamethasone Levels After DEXtenza

Status:
Not yet recruiting

Trial end date:
2021-03-01

Target enrollment:

Participant gender:

Summary

A prospective, open-label, interventional study to determine intraocular concentration levels of dexamethasone following use of the DEXTENZA® implant.

Phase:

Phase 4

Details

Lead Sponsor:

Nathan Steinle

Collaborator:

Ocular Therapeutix, Inc.

Treatments:

Dexamethasone